Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy

Table 1

Patient demographics.

A total number of patients	40
Age (yrs.)	66.5 ± 10.3 (range: 48 to 86)
Male : female	16 : 24
POAG : NTG : OH	29 : 9 : 2
Previous PGA (latanoprost : travoprost)	32 : 8
Previous ocular disease	Cataract	4
	Dry eye	1
	Chorioretinal atrophy	1
	Allergic conjunctivitis	2
	Episcliritis	1
Previous ocular surgery	Trabeculectomy	2
	Phacoemulsification plus intraocular lens insertion	4
Concomitant systemic disease	Hypertension	8
	Diabetic mellitus	5
	Hyperglycemia	4

POAG: primary open-angle glaucoma; NTG: normal-tension glaucoma; OH: ocular hypertension.